The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126234521 12623452 1 I 20160523 20160525 20160804 20160804 EXP JP-ABBVIE-16P-087-1638684-00 ABBVIE 0.00 F Y 47.00000 KG 20160804 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126234521 12623452 1 PS POPSCAINE LEVOBUPIVACAINE HYDROCHLORIDE 1 Other PERINEURAL FOR RECTUS SHEATH BLOCK Y UNKNOWN 0 60 ML INJECTION
126234521 12623452 2 SS ESLAX ROCURONIUM BROMIDE 1 Intravenous drip Y UNKNOWN 0 QD
126234521 12623452 3 SS FENTANYL CITRATE. FENTANYL CITRATE 1 Intravenous (not otherwise specified) ADMINISTERED AT UNKNOWN TIMES Y UNKNOWN 0 550 UG
126234521 12623452 4 SS FENTANYL CITRATE. FENTANYL CITRATE 1 Intravenous drip 18 MCG/HR Y UNKNOWN 0 QD
126234521 12623452 5 C SEVOFLURANE. SEVOFLURANE 1 Respiratory (inhalation) 0 QD
126234521 12623452 6 C SUPRANE DESFLURANE 1 Respiratory (inhalation) 3%-4% 0 QD
126234521 12623452 7 C ULTIVA REMIFENTANIL HYDROCHLORIDE 1 Intravenous drip 0.03-0.2 MCG/KG/MIN 0 QD
126234521 12623452 8 C BRIDION SUGAMMADEX 1 Intravenous (not otherwise specified) 0 BID
126234521 12623452 9 C HEPARIN HEPARIN SODIUM 1 Intravenous (not otherwise specified) 0 QD
126234521 12623452 10 C PROTAMINE SULFATE MOCHIDA 2 Intravenous (not otherwise specified) 0 QD
126234521 12623452 11 C CEFAZOLIN SODIUM. CEFAZOLIN SODIUM 1 Intravenous drip 0 TID
126234521 12623452 12 C HYDROCORTONE HYDROCORTISONE 1 Intravenous (not otherwise specified) 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126234521 12623452 1 Postoperative analgesia
126234521 12623452 2 Hypotonia
126234521 12623452 3 Analgesic therapy
126234521 12623452 5 Maintenance of anaesthesia
126234521 12623452 6 Maintenance of anaesthesia
126234521 12623452 7 Analgesic therapy
126234521 12623452 8 Neuromuscular blockade reversal
126234521 12623452 9 Anticoagulant therapy
126234521 12623452 10 Procoagulant therapy
126234521 12623452 11 Infection prophylaxis
126234521 12623452 12 Allergy prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126234521 12623452 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126234521 12623452 Anaesthetic complication
126234521 12623452 Overdose

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126234521 12623452 1 20160523 20160523 0
126234521 12623452 2 20160523 20160523 0
126234521 12623452 3 20160523 20160523 0
126234521 12623452 4 20160523 20160523 0
126234521 12623452 5 20160523 20160523 0
126234521 12623452 6 20160523 20160523 0
126234521 12623452 7 20160523 20160523 0
126234521 12623452 8 20160523 20160523 0
126234521 12623452 9 20160523 20160523 0
126234521 12623452 10 20160523 20160523 0
126234521 12623452 11 20160523 20160523 0
126234521 12623452 12 20160523 20160523 0